MECP2 and atypical Rett syndrome: Xiang and colleagues (2020) recently identified BRD4 as a critical factor in Rett syndrome (RTT), an X-linked neurodevelopmental disorder caused, in most cases, by loss of function in methyl-CpG binding protein 2 (MeCP2).